The Philippine government will adopt the emergency use of the UAE-developed Hayat-Vax vaccines with the clearance of the Food and Drug Administration (FDA) in order to enhance immunization coverage.
According to FDA chief Rolando Enrique Domingo, the Hayat-Vax, which was supplied by the UAE government, is comparable in composition to China’s Sinopharm vaccine and is prescribed for anyone aged 18 and up.
FDA Approves Emergency Use of Hayat-Vax Vaccines from UAE
According to Reuters, the Hayat-Vax is the result of a collaboration between Sinopharm, a Chinese pharmaceutical company, and Group 42, an Abu Dhabi-based corporation.
During its experimental phase, the vaccine had an 86 percent efficiency rate, according to the UAE.
AstraZeneca, Johnson & Johnson, Moderna, Pfizer, Sinovac, and Sputnik V are some of the current emergency vaccinations used in the Philippines.
Meanwhile, the Philippines got an extra 100,000 doses of the Sinopharm vaccine from the UAE on Wednesday.
According to a spokeswoman from the UAE’s National Emergency Crisis and Disaster Management Authority (NCEMA), the Sinopharm vaccine was made in the traditional way using an inactive virus.
“So, this gives a greater safety and efficacy percentage to protect against dangerous complications. The vaccine has also proven to be effective in many countries worldwide that have participated in its clinical trials at various stages,” the health official added.